Cellplus Bio is a cell culture media company helping biopharmaceutic developers & manufacturers to unleash the full potential of any cell type.

Since more than 15 years, the core team members of Cellplus Bio have successfully served a large number of biopharmaceutical developers and manufacturers with their rich experiences & know-how in serum-free cell culture media development, large-scale GMP manufacturing, quality management system and global project management.

Leveraging the synergy of the team’s expertise & the strategic investment from a globally leading life-science solutions provider, Cellplus Bio, founded in early 2021 in Suzhou, China, provides the biotech industry with a variety of proprietary, off-the-shelf cell culture media for manufacturing of therapeutic antibodies & recombinant proteins, viruses such as AAV and Lenti-virus, human or veterinary vaccines. The large-scale GMP manufacturing capability relies on 2 state-of-the-art dry powder production lines with a maximum annual capacity of 200 tons/year (equivalent to 10 million Liters of a cell culture medium for CHO-K1). In addition, Cellplus Bio offers reliable, sterile GMP liquid solutions with a current capacity of 90000L/year which will be expanded to 500K L/year in 2024.

We believe in long-term value through collaboration with our customers and partners that can only be built on consistent quality on all levels within our operations.

Please feel warmly invited to meet our team, and to visit our facility in Suzhou!